Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next three days.
In the meantime, you can enjoy access to all the latest news, events and resources for different therapy areas on our website.Products
Duodart
(dutasteride and tamsulosin)
Duodart is indicated for: 1
- Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH)
- Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severesymptoms of BPH
Avodart
(dutasteride)
Avodart is indicated for: 2
- As monotherapy: for the treatment and control of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of the need for BPH-related surgery
- Combination With Alpha-Blocker: for the treatment of symptomatic BPH in men with an enlarged prostate
Trade marks are owned by or licensed to the GSK group of companies.
©2021 GSK group of companies or its licensor.
